UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000047268
Receipt No. R000053895
Scientific Title Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study
Date of disclosure of the study information 2022/03/23
Last modified on 2022/05/16 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study
Acronym Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study
Scientific Title Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study
Scientific Title:Acronym Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study
Region
Japan

Condition
Condition healthy adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We aimed to conduct an introduction test of the TLF label with the nutrition label affixed to the front of the food packaging and to verify its practicality when used for long periods in young people.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Compare dietary choices between the TLF-labeled and non-TLF-labeled groups for a week.
Key secondary outcomes 1) Compare the increase and decrease in the number of people who are conscious of a healthy diet in the TLF label use group and the non-use group.

2) Evaluate which of the nutritional components that should be noted for overdose will become conscious in the TLF label use group and the non-use group. (Calorie, fat, saturated fatty acid, sugar, salt, etc.)

3) Evaluate whether there is a difference in how stress is felt between the TLF label use group and the non-use group.


Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation NO
Institution consideration
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Other
Interventions/Control_1 Intervention group: Select a meal once a day with the nutrition label (TLF label) when choosing a meal at dinner (for seven consecutive days)
Interventions/Control_2 Control group. Select a meal once a day at dinner without nutrition labeling (TLF labeling) (7 consecutive days)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
30 years-old >
Gender Male and Female
Key inclusion criteria Those who have received sufficient explanation about the purpose and contents of this research, have the ability to consent, volunteered voluntarily after fully understanding, and agreed to participate in writing.
Key exclusion criteria Key exclusion criteria:
1) refuse to participate in the study;
2) Those who have dietary restrictions as a result of metabolic or endocrine disorders
3) People with eating disorders
4) Those who have anorexia
5) Those who have intentionally or unintentionally gained or lost weight by more than 5% in the past 3 months
6) are deemed ineligible by principal investigator for other reasons not listed above.
Target sample size 68

Research contact person
Name of lead principal investigator
1st name Nobuyuki
Middle name
Last name Wakui
Organization Hoshi University
Division name Division of Applied Pharmaceutical Education and Research
Zip code 142-8501
Address 2-4-41 Ebara, Shinagawa-ku, Tokyo
TEL 03-5498-5760
Email n-wakui@hoshi.ac.jp

Public contact
Name of contact person
1st name Nobuyuki
Middle name
Last name Wakui
Organization Hoshi University
Division name Division of Applied Pharmaceutical Education and Research
Zip code 142-8501
Address 2-4-41 Ebara, Shinagawa-ku, Tokyo
TEL 03-5498-5760
Homepage URL
Email n-wakui@hoshi.ac.jp

Sponsor
Institute Hoshi University
Institute
Department

Funding Source
Organization Hoshi University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hoshi University Research Ethics Committee
Address 142-8501, 2-4-41 Ebara, Shinagawa-ku, Tokyo
Tel 03-3786-1011
Email somu@hoshi.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 03 Month 23 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 03 Month 16 Day
Date of IRB
2022 Year 03 Month 16 Day
Anticipated trial start date
2022 Year 03 Month 24 Day
Last follow-up date
2022 Year 05 Month 16 Day
Date of closure to data entry
2022 Year 05 Month 16 Day
Date trial data considered complete
2022 Year 05 Month 16 Day
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 03 Month 23 Day
Last modified on
2022 Year 05 Month 16 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053895